Surgeon decision-making for management of positive sentinel lymph nodes in the post-Multicenter Selective Lymphadenectomy Trial II era: A survey study.
Jane Yuet Ching HuiErin BurkeKristy Kummerow BromanSchelomo MarmorEric JensenTodd M TuttleJonathan S ZagerPublished in: Journal of surgical oncology (2020)
Most surgeon respondents are aware of MSLT-II, but its application in practice varies according to several clinicopathologic and surgeon factors.